domingo, 20 de setembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 12, 2026

Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm

View original at globenewswire.com
Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm RADNOR, Pa., Feb…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • OpenAI could account for more than a third of total Oracle revenues by fiscal 2028 and even a greater share by fiscal 2030

    80% confidence
  • Oracle really matters because it is the harbinger of the AI capex boom, and this repricing in debt markets is very consistent with the view that risks are building

    80% confidence
  • Blue Owl Capital pulled out of funding a $10 billion Oracle data center intended to serve OpenAI as a result of concerns about Oracle's spending commitments and rising debt levels

    80% confidence
  • Oracle's $248 billion lease commitment disclosure is a bombshell disclosure, with lease commitments increasing massively from just under $100 billion in the prior quarter

    80% confidence
  • Oracle pushed back completion dates for data centers developing for OpenAI to 2028 from 2027 due to labor and material shortages

    80% confidence
  • Oracle's promises of massive new revenues from its increased AI infrastructure business were unlikely to materialize

    80% confidence
  • Oracle's AI infrastructure strategy would result in massive increases in CapEx without equivalent, near-term growth in revenue; the Company's substantially increased spending created serious risks involving Oracle's debt and credit rating, free cash flow, and ability to fund its projects

    80% confidence
  • Oracle stock price target of $175, representing a 40% pullback

    80% confidence
  • OpenAI's ability to meet contractual obligations will be contingent on AI tailwinds continuing and its models being a market leader to continue to raise external financing

    80% confidence
  • Oracle expects to spend less than $100 billion on AI growth plans

    80% confidence
  • The Company's substantially increased spending on AI infrastructure would rapidly convert into accelerating revenue and profit growth

    80% confidence
  • Oracle's future lease exposure far exceeds similar commitments by peers, with a mismatch between the long duration of the property leases and much shorter contracts with key customers such as OpenAI

    80% confidence
  • Oracle has very good line-of-sight for capabilities to spend on CapEx right before it starts generating revenue

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
Sinalizamos conflitos abertamente ›
Verificado recentemente
Verificado com a fonte original
4,982
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,982 factos verificados com a fonte5,299 documentos-fonte arquivados
Consulte estes dados → isubstrate.com